Canadian Urologic Oncology Group Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2004
NCT00268710
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now